Neurological
|
January 20, 2025

Understanding Dextroamphetamine-Amphetamine for ADHD and Narcolepsy

Written By
Dr. Emilie Wilson ND, L.Ac.
Medically Reviewed by
Updated On
January 28, 2025

Diagnoses of ADHD (Attention Deficit Hyperactivity Disorder) are on the rise in the US, and narcolepsy may be an underdiagnosed condition

A survey of parents showed that an estimated 7 million U.S. children (11.4%) were diagnosed with ADHD as of 2022, and 15.5 million adults (6%) were diagnosed with ADHD as of 2023. 

In the U.S. and Western Europe, approximately 1 in 2000 people are diagnosed with narcolepsy, but narcolepsy might often go undiagnosed, particularly in cases with mild symptoms.

These conditions can profoundly impact daily life, but medications like dextroamphetamine-amphetamine have provided effective solutions for many individuals. 

Dextroamphetamine-amphetamine, a central nervous system (CNS) stimulant, has helped improve focus, attention, and wakefulness in those who need it most. This article provides a balanced look at the medication, exploring its uses, benefits, risks, and practical considerations for patients and caregivers.

[signup]

What is Dextroamphetamine-Amphetamine?

Dextroamphetamine-amphetamine is a CNS stimulant commonly prescribed under brand names like Adderall. It is FDA-approved to treat ADHD and narcolepsy

As an amphetamine drug, dextroamphetamine-amphetamine carries a high risk for the potential of misuse and abuse and is therefore classified as a Schedule II controlled substance by the Drug Enforcement Agency (DEA).

By improving concentration and decreasing impulsivity in ADHD patients, and promoting wakefulness in those with narcolepsy, it addresses some of the most debilitating symptoms of these conditions.

Some healthcare providers may use dextroamphetamine-amphetamine off-label for purposes such as improving movement in stroke patients. However, these uses are not FDA-approved and carry potential risks that should be discussed with a provider.

As a Schedule II controlled substance, it carries a high risk of misuse and dependency, requiring close monitoring by a prescribing healthcare professional.

Mechanism of Action: How Dextroamphetamine-Amphetamine Works

Dextroamphetamine-amphetamine increases the availability of neurotransmitters like dopamine and norepinephrine by promoting their release and inhibiting reuptake, which supports improved focus and alertness in individuals with ADHD.

The medication also affects the heart and blood vessels, increasing heart rate and blood flow to muscles while tightening blood vessels to raise blood pressure.

In individuals with ADHD, norepinephrine and dopamine are often imbalanced, leading to symptoms like inattention and hyperactivity. Dextroamphetamine-amphetamine restores balance, helping patients concentrate better and manage their behaviors.

Interestingly, the effects differ in people without ADHD. In these individuals, the drug may cause overstimulation or euphoria, which contributes to the drug’s potential for misuse, this is why it’s classified as a controlled substance.

Dextroamphetamine-Amphetamine (Adderall) vs. Methylphenidate (Ritalin) in ADHD

Methylphenidate (Ritalin) and dextroamphetamine-amphetamine (Adderall) are stimulants used to treat ADHD and narcolepsy by increasing dopamine and norepinephrine levels in the brain, but they differ in their mechanisms and effects. 

Methylphenidate primarily blocks the reuptake of dopamine and norepinephrine, while dextroamphetamine-amphetamine also promotes the release of these neurotransmitters and slows their breakdown: this combined action often results in a longer duration of action, although clinical effects may vary. 

While both medications are effective and available in immediate- and extended-release forms, dextroamphetamine-amphetamine may cause more side effects, such as insomnia and weight loss, making methylphenidate a better option for those who are sensitive to these issues.

Dextroamphetamine-amphetamine, however, is often preferred for patients needing stronger or longer-lasting symptom control. Both require careful monitoring due to cardiovascular risks and the potential for misuse.

Treatment selection often depends on individual responses, side effect profiles, and specific patient needs.

Medical Uses and Benefits

Despite carrying serious risks, dextroamphetamine-amphetamine can help ADHD and/or narcolepsy patients struggling with daily life. 

ADHD Treatment

ADHD affects both children and adults, making daily tasks like completing schoolwork or maintaining focus at work difficult. In these patients, dextroamphetamine-amphetamine can:

  • Improve focus and attention: patients often report being able to complete tasks more efficiently.
  • Reduce impulsivity: this helps in both social and professional settings.
  • Enhance organization skills: managing time and responsibilities becomes easier.

ADHD medication is most effective when combined with behavioral therapy, coaching, or other interventions tailored to the individual.

Managing Narcolepsy

Narcolepsy is a chronic sleep disorder that makes it hard for the body to control sleep and wake cycles. 

Narcolepsy develops when brain cells in the hypothalamus, called orexin (or hypocretin) neurons, stop working or are lost. Normally, these cells help keep you awake and control when you go into deep sleep. 

In type 1 narcolepsy, most of these cells are lost, causing symptoms like extreme daytime sleepiness, sudden muscle weakness (cataplexy), feeling paralyzed when waking up or falling asleep (sleep paralysis), and dream-like experiences while awake or asleep while also understanding that what the person is seeing is “just a dream” (hypnagogic hallucinations). 

Weight gain and stress in daily life, work, and relationships are also common effects of narcolepsy.

This loss of orexin cells may be caused by an autoimmune attack on these brain cells, sometimes triggered by an infection. 

Type 2 narcolepsy is less severe and doesn’t include cataplexy, although patients can still experience other symptoms of narcolepsy; there is currently no known cause of type 2 narcolepsy. 

Dextroamphetamine-amphetamine helps people with narcolepsy stay awake by increasing the levels of stimulating brain chemicals like dopamine, serotonin, and norepinephrine. It is used to treat daytime sleepiness, especially if other medications like modafinil don’t work well enough.

Off-Label Uses

Amphetamines are sometimes used off-label to help stroke patients regain movement. However, while preclinical animal studies suggested that dextroamphetamine might help with stroke recovery, human trials have not shown the same benefit. 

This medication is also used by some college students to improve focus, memory, and study for long periods, but this is not medically recommended due to the risks of misuse and addiction. 

Dosage and Administration

Dosage recommendations must be strictly adhered to for maximum effectiveness and a reduced risk of side effects.

Dosage Guidelines

Standard dosages for dextroamphetamine-amphetamine vary by age and condition. Patients work closely with their ordering provider to determine the appropriate dosage for their needs.

Dosages by age and condition:

  • Children with ADHD: start at 2.5 mg (ages 3-5) or 5 mg (ages 6+), increase weekly. Max: 40 mg/day.
  • Adults with ADHD/Narcolepsy: start at 10 mg/day, increase weekly by 10 mg. Usual range: 5-60 mg/day.

Adjustments depend on:

  • Age, weight, medical conditions (e.g., cardiovascular or psychiatric issues).

The general recommendation is for a low-dose start and gradual increase:

  • Weekly increments (2.5-10 mg) minimize side effects.

Max dose:

  • Adults with Narcolepsy and/or ADHD: up to 60 mg/day

Best Practices for Administration

To get the most out of this medication:

  • Take it in the morning to avoid insomnia.
  • If you miss a dose, skip it instead of doubling up to avoid overstimulation.
  • Make sure to attend regular followup appointments with your prescribing provider, who will monitor you for potential side effects including unwanted weight changes, increased blood pressure, and/or signs of dependence or addiction.

Potential Drug Interactions with Dextroamphetamine-Amphetamine

This medication has the potential to interact with several medications and supplements. Always discuss your current medication and supplement regimen with your ordering provider.

Drugs

Monoamine Oxidase Inhibitors (MAOIs)

  • Examples: Isocarboxazid, Linezolid, Phenelzine, Tranylcypromine
  • Interaction: risk of dangerously high blood pressure; avoid use within 14 days due to the risk of hypertensive crisis, per FDA guidelines.

Thiazide Diuretics

  • Examples: Hydrochlorothiazide (HCTZ), Chlorothiazide
  • Interaction: increases amphetamine levels in the body, raising the risk of side effects.

Medications That Affect Serotonin (CYP2D6 Inhibitors)

  • Examples: Certain antidepressants
  • Interaction: raises risk of serotonin syndrome, a potentially life-threatening condition.

Antacids and Heartburn Medications

  • Examples: Cimetidine, Omeprazole, Esomeprazole
  • Interaction: enhances amphetamine absorption, increasing its effects.

Heart or Blood Pressure Medications

  • Interaction: may exacerbate heart-related side effects of amphetamines.

Allergy Medications

  • Examples: Diphenhydramine, Loratadine, Cetirizine
  • Interaction: can cause sedation or other side effects when combined.

Supplements and Non-Prescription Products

Vitamin C (Ascorbic Acid)

  • Interaction: reduces effectiveness of amphetamines.

St. John’s Wort

  • Interaction: interferes with how the body processes amphetamines.

Nutritional Supplements

  • Examples: Glutamic Acid (L-glutamine), Tryptophan
  • Interaction: may affect neurotransmitter levels, altering drug efficacy and potentially increasing the risk of serious side effects like serotonin syndrome.

Sodium Bicarbonate and Sodium Phosphate

  • Examples: Baking Soda, Soda Mint
  • Interaction: Increases amphetamine absorption, enhancing effects.

Important Notes

Patients should always disclose all medications and supplements they are taking to their prescribing provider to minimize the risk of adverse interactions.

Some interactions may require dose adjustments or extra monitoring to ensure safety.

Side Effects and Risks

As with any medication, dextroamphetamine-amphetamine comes with its own risks for side effects.

Common Side Effects

Cardiovascular:

  • Increased systolic blood pressure

Neurologic:

Endocrine/Metabolic:

  • Loss of appetite

Gastrointestinal (GI):

  • Dry mouth
  • Abdominal pain
  • Nausea

Psychiatric:

  • Nervousness
  • Mood swings

Serious Side Effects

Cardiovascular:

  • Cardiomyopathy
  • Myocardial infarction (heart attack)
  • Peripheral vascular disease
  • Raynaud's disease
  • Sudden cardiac death

Neurologic:

  • Stroke (cerebrovascular accident)
  • Seizures

Dermatologic:

  • Stevens-Johnson syndrome
  • Toxic epidermal necrolysis

Immunologic:

  • Hypersensitivity reactions

Psychiatric:

  • New or worsening symptoms of psychosis
  • Mania
  • Emotional instability
  • Behavioral changes

Other Adverse Events

Toxicity Symptoms:

  • Hyperactivity
  • Overheating (hyperthermia)
  • Dilated pupils (mydriasis)
  • Tremors
  • Altered mental status
  • Seizures

Overdose Symptoms:

  • Agitation
  • Psychosis
  • Hypertension
  • Rhabdomyolysis (muscle breakdown)
  • Organ dysfunction (e.g., kidney issues)

Withdrawal Symptoms:

  • Depression
  • Fatigue

Report any side effects to your doctor right away to ensure the medication remains safe and effective. Serious side effects, such as cardiovascular complications, should be reported to a healthcare provider immediately.

Addressing Misuse and Dependency Risks

As a controlled substance, dextroamphetamine-amphetamine carries a risk of abuse and dependency. Strategies to prevent misuse include:

  • Regular follow-ups with healthcare providers.
  • Using pill counts or pharmacy monitoring to track usage.
  • Educating patients and caregivers about the importance of proper use.

Patients should attend regular follow-ups to monitor for any long-term effects or dependency risks.

Long-Term Effects and Safety

Long-term use of this medication has been well-studied. While generally safe under medical supervision, prolonged use may:

  • Slightly suppress growth in children and/or promote excessive weight gain.
  • Increase the risk of cardiovascular issues in predisposed individuals.
  • Regular check-ups and monitoring mitigate these risks, ensuring continued safety.

Practical Tips for Patients and Caregivers

ADHD and narcolepsy are both considered chronic conditions; setting appropriate expectations and practicing a healthy, balanced lifestyle can promote a patient’s overall well-being and support satisfaction with their treatment plan.

Managing Expectations

Set realistic goals: medication won’t “cure” ADHD or narcolepsy but can significantly improve symptoms.

Track progress: tools like symptom trackers can monitor improvement and side effects.

Consider alternatives: if the medication doesn’t work well or causes intolerable side effects, discuss other options with your provider.

Supporting Emotional Well-being

Address stigma: taking stimulant medication is a legitimate medical treatment. Join support groups or seek counseling if stigma becomes a concern.

Communication strategies: for children, involve teachers and caregivers in treatment plans to ensure consistency and understanding.

Building a Holistic Treatment Plan

Maximize benefits by integrating:

  • Therapeutic support: behavioral therapy or ADHD coaching can address challenges medication alone cannot.

[signup]

Key Takeaways

  • ADHD Diagnoses on the Rise: as of 2023, over 15.5 million U.S. adults and 7 million children have been diagnosed with ADHD.
  • Narcolepsy Underdiagnosed: while 1 in 2,000 people are diagnosed in the U.S. and Western Europe, many with mild symptoms may go undiagnosed, missing vital treatment opportunities.
  • Dextroamphetamine-Amphetamine's Role: this CNS stimulant improves focus, attention, and wakefulness, offering effective symptom management for ADHD and narcolepsy under proper medical supervision.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Adderall ® CII (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets). (2017). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/011522s043lbl.pdf

Amphetamines WHAT ARE AMPHETAMINES? (2020). https://www.dea.gov/sites/default/files/2020-06/Amphetamines-2020_0.pdf

Bonvalet, M., Ollila, H. M., Ambati, A., & Mignot, E. (2017). Autoimmunity in narcolepsy. Current opinion in pulmonary medicine, 23(6), 522–529. https://doi.org/10.1097/MCP.0000000000000426

Bryant, A. (2024, September 2). How to Have a Good Night Sleep: Top Proven Strategies for Better Rest. Rupa Health. https://www.rupahealth.com/post/how-to-have-a-good-night-sleep-top-proven-strategies-for-better-rest 

Bryant, A. (2024, August 2). Understanding Arrhythmias: Types, Symptoms, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/arrhythmias-basics-types-symptoms-diagnosis-treatment 

CDC. (2024, May 15). Data and Statistics on ADHD. Attention-Deficit / Hyperactivity Disorder (ADHD); CDC. https://www.cdc.gov/adhd/data/index.html

Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesity 

Cloyd, J. (2023, July 28). A functional medicine diarrhea protocol: Comprehensive lab testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-diarrhea-protocol-comprehensive-lab-testing-therapeutic-diet-and-supplements 

Cloyd, J. What is Dopamine’s Role in ADHD? (2024, March 13). Rupa Health. https://www.rupahealth.com/post/what-is-dopamines-role-in-adhd 

Daglis, S. (2024, August 7). Tachycardia: Don't Let Your Heart Run Away with You. Rupa Health. https://www.rupahealth.com/post/tachycardia-dont-let-your-heart-run-away-with-you 

Del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological psychiatry, 69(12), e145–e157. https://doi.org/10.1016/j.biopsych.2011.02.036

Dextroamphetamine: Uses & Side Effects. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/20878-dextroamphetamine-tablets

Dextroamphetamine and Amphetamine: MedlinePlus Drug Information. (2023). Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a601234.html

Faraone S. V. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience and biobehavioral reviews, 87, 255–270. https://doi.org/10.1016/j.neubiorev.2018.02.001

Golden, E. C., & Lipford, M. C. (2018). Narcolepsy: Diagnosis and management. Cleveland Clinic Journal of Medicine, 85(12), 959–969. https://doi.org/10.3949/ccjm.85a.17086

Goldstein L. B. (2000). Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology, 39(5), 852–859. https://doi.org/10.1016/s0028-3908(99)00249-x

Goldstein, L. B., Lennihan, L., Rabadi, M. J., Good, D. C., Reding, M. J., Dromerick, A. W., Samsa, G. P., & Pura, J. (2018). Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial. JAMA neurology, 75(12), 1494–1501. https://doi.org/10.1001/jamaneurol.2018.2338

Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs 

Lakhan, S. E., & Kirchgessner, A. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain and behavior, 2(5), 661–677. https://doi.org/10.1002/brb3.78

Magnus W, Anilkumar AC, Shaban K. Attention Deficit Hyperactivity Disorder. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441838/

Narcolepsy: MedlinePlus Genetics. (2018, June 1). Medlineplus.gov. https://medlineplus.gov/genetics/condition/narcolepsy/

Nazarova, V. A., Sokolov, A. V., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2022). Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in pharmacology, 13, 1066988. https://doi.org/10.3389/fphar.2022.1066988

Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease 

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches 

Norepinephrine. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/norepinephrine 

Qu, S., Wang, P., Wang, M., Li, C., Dong, X., Xu, L., & Han, F. (2022). A comparison of mood, quality of life and executive function among narcolepsy type 1 patients with or without ADHD symptoms in China. Sleep Medicine, 97, 47–54. https://doi.org/10.1016/j.sleep.2022.05.016

Sharbaf Shoar N, Marwaha R, Molla M. Dextroamphetamine-Amphetamine. [Updated 2023 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507808/

Slowik JM, Collen JF, Yow AG. Narcolepsy. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459236/

Staley, B. S., Robinson, L. R., Claussen, A. H., Katz, S. M., Danielson, M. L., Summers, A. D., Farr, S. L., Blumberg, S. J., & Tinker, S. C. (2024). Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. MMWR. Morbidity and Mortality Weekly Report, 73(40), 890–895. https://doi.org/10.15585/mmwr.mm7340a1

Sum-Ping, O., & Mignot, E. (2023). What Is Narcolepsy? JAMA, 329(20), 1802. https://doi.org/10.1001/jama.2023.5149

Verghese C, Patel P, Abdijadid S. Methylphenidate. [Updated 2024 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482451/

Wang, C., Wang, Q., Ji, B., Pan, Y., Xu, C., Cheng, B., Bai, B., & Chen, J. (2018). The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Frontiers in molecular neuroscience, 11, 220. https://doi.org/10.3389/fnmol.2018.00220‌

Weinberg, J. (2022, November 16). 4 Science Backed Health Benefits of The Mediterranean Diet. Rupa Health. https://www.rupahealth.com/post/4-science-backed-health-benefits-of-the-mediterranean-diet 

Yoshimura, H. (2023, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview 

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Neurological
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.